Think of Enterprise Value as the theoretical takeover price. It is more comprehensive than market capitalization (Market Cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Drug Free Solution's Enterprise Value is $0.06 Mil.
Drug Free Solution's EBIT for the trailing twelve months (TTM) ended in Feb. 2014 was $-0.87 Mil. Therefore, Drug Free Solution's EV-to-EBIT ratio for today is -0.07.
EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA. As of today, Drug Free Solution's Enterprise Value is $0.06 Mil.
Drug Free Solution's EBITDA for the trailing twelve months (TTM) ended in Feb. 2014 was $-0.86 Mil. Therefore, Drug Free Solution's EV-to-EBITDA ratio for today is -0.07.
EV-to-Revenue is calculated as Enterprise Value divided by its Revenue. As of today, Drug Free Solution's Enterprise Value is $0.06 Mil.
Drug Free Solution's Revenue for the trailing twelve months (TTM) ended in Feb. 2014 was $0.00 Mil. Therefore, Drug Free Solution's EV-to-Revenue ratio for today is 28.50.
*** Please note that the current Enterprise Value is calculated using the current market capitalization and the most recently available financial data. If key financial fields—Long-Term Debt & Capital Lease Obligation and Short-Term Debt & Capital Lease Obligation—are recorded as null in the latest reporting period, our data vendor will default to using data from the prior period with valid entries.
Drug Free Solution (OTCPK:DSOL) Enterprise Value Explanation
When an investor buy a company, the investor needs to pay not only the common shares, he/she also needs to pay the shareholders of Preferred Stocks. He also assumes the debt of the company, and receives the cash on the company's balance sheet.
If a company has more cash than debt, the investor actually pays less than the Market Cap because he immediately owns the cash once the transaction goes through.
The market value of Preferred Stock needs to be added to the market value of common stocks in the calculation of Enterprise Value.
For the companies with the same Market Cap, the smaller the Enterprise Value is, the cheaper the company is.
Enterprise Value can be negative when the company's net cash is more than its Market Cap. In this case the investor is basically getting the company for free and get paid for that.
1. EV-to-EBIT is calculated as Enterprise Value divided by its EBIT.
Drug Free Solution's current Enterprise Value is $0.06 Mil.
Drug Free Solution's EBIT for the trailing twelve months (TTM) ended in Feb. 2014 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.87 Mil.
2. EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA.
Drug Free Solution's current Enterprise Value is $0.06 Mil.
Drug Free Solution's EBITDA for the trailing twelve months (TTM) ended in Feb. 2014 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.86 Mil.
Drug Free Solution's current Enterprise Value is $0.06 Mil.
Drug Free Solution's Revenue for the trailing twelve months (TTM) ended in Feb. 2014 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.
Drug Free Solution's current Enterprise Value is $0.06 Mil.
Drug Free Solution's Cash Flow from Operations for the trailing twelve months (TTM) ended in Feb. 2014 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.74 Mil.
Drug Free Solution's current Enterprise Value is $0.06 Mil.
Drug Free Solution's Free Cash Flow for the trailing twelve months (TTM) ended in Feb. 2014 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.74 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Drug Free Solution Enterprise Value Related Terms
Drug Free Solution Enterprise Value Historical Data
* Premium members only.
The historical data trend for Drug Free Solution's Enterprise Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
DSOL vs USEL, ZZLL, WSCO: Enterprise Value Comparison
For the Health Information Services subindustry, Drug Free Solution's Enterprise Value, along with its competitors' market caps and Enterprise Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Drug Free Solution Enterprise Value vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Drug Free Solution's Enterprise Value distribution charts can be found below:
* The bar in red indicates where Drug Free Solution's Enterprise Value falls into.
Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
Drug Free Solution's Enterprise Value for the fiscal year that ended in May. 2013 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Drug Free Solution (DSOL) has a Enterprise Value of $0.06 Mil as of Jun. 26, 2026. Enterprise value equals the sum of market cap, debt and preferred shares less cash and equivalents. View historical data on Drug Free Solution and its competitors.
Is Drug Free Solution's Enterprise Value too high?
Drug Free Solution's current Enterprise Value is $0.06 Mil.
How does Drug Free Solution's Enterprise Value compare to USEL and ZZLL?
Drug Free Solution's Enterprise Value of $0.06 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Enterprise Value for a Healthcare Providers & Services company?
A good Enterprise Value depends on the Healthcare Providers & Services industry context. However, Enterprise Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Enterprise Value mean?
A high Enterprise Value can signal that a stock is expensive relative to its fundamentals. Enterprise value equals the sum of market cap, debt and preferred shares less cash and equivalents. View historical data on Drug Free Solution and its competitors. Drug Free Solution's current Enterprise Value is $0.06 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Drug Free Solution stock overvalued right now?
Drug Free Solution (DSOL) has a current Enterprise Value of $0.06 Mil. The current Enterprise Value is $0.06 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Enterprise Value calculated?
Enterprise Value is calculated from a company's financial statements. For Drug Free Solution (DSOL), the current Enterprise Value is $0.06 Mil as of Jun. 26, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Drug Free Solution Inc is a United States based holding company that owns and operates various subsidiaries in the healthcare industry. It is focused on acquiring healthcare operations that focus on Home Healthcare, Developmental Disabilities, Hospice Care, Skilled Nursing, Residential Rehabilitation, Home & Community Based Services.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
DSOL has been successfully added to your 